drugset / Trial / NCT06745856

Intraoperative 5-fluorouracil Augmentation of Trabeculectomy

NCT06745856 ↗

Phase 3 Completed 368 enrolled Moorfields Eye Hospital NHS Foundation Trust
RandomizedParallel-groupQuadruple-blindTreatment

Summary

5-fluorouracil (5FU) is an antimetabolite that has been demonstrated to have beneficial effects when injected into the subconjunctival space after glaucoma surgery (trabeculectomy). The hypothesis of this study is that a similar beneficial effect can be achieved with a single intraoperative application of 5FU. This hypothesis is tested with a randomized control study.

Timeline

Start
1996-04
Primary completion
2000-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator fluorouracil Small molecule 50 mg/ml Other

Indications